6) Nano-formulations Nano-formulations are advanced drug delivery systems in which active pharmaceutical ingredients (APIs) are formulated at the nanoscale, typically with particle sizes less than 1 m [30, 31]
thus, currently available data do not provide sufficient evidence to support the clinical efficacy of aducanumab
GIP is involved in glucose and lipid metabolism, GLP-1 regulates insulin secretion and appetite, and GCG plays a role in fat breakdown for energy use
Why natural support is the new wave in pet health Unlike pharmaceutical drugs that mimic GLP-1, new research focuses on stimulating the bodys own production of this hormonein both people and pets
11,12 Notably, the potential neuroprotective properties of GLP-1 RAs extend to conditions like Alzheimer disease (AD) and Parkinson disease by ameliorating motor impairment and curtailing oxidative stress, inflammation, and apoptosis